Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Finished Drug Prices
NA
1. (4-((3s)-3-(((1r)-1-(1-naphthyl)ethyl)amino)-1-pyrrolidinyl)phenyl)acetic Acid
1. 870964-67-3
2. Evocalcet [inn]
3. Mt-4580
4. Khk-7580
5. Khk7580
6. E58mlh082p
7. 4-[(3s)-3-[[(1r)-1-(1-naphthalenyl)ethyl]amino]-1-pyrrolidinyl]benzeneaceticacid
8. 2-[4-[(3s)-3-[[(1r)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic Acid
9. 4-[(3s)-3-[[(1r)-1-(1-naphthalenyl)ethyl]amino]-1-pyrrolidinyl]benzeneacetic Acid
10. Benzeneacetic Acid, 4-((3s)-3-(((1r)-1-(1-naphthalenyl)ethyl)amino)-1-pyrrolidinyl)-
11. 2-(4-((s)-3-(((r)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetic Acid
12. 2-[4-[(3s)-3-[[(1r)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]ethanoic Acid
13. Unii-e58mlh082p
14. Evocalcet?
15. H43
16. Orkedia (tn)
17. Evocalcet (jan/inn)
18. Evocalcet [jan]
19. Evocalcet [mi]
20. Evocalcet [who-dd]
21. Gtpl9042
22. Chembl4297621
23. Schembl14668291
24. Khk7580khk7580
25. Dtxsid101132784
26. Vjb96467
27. Akos040741717
28. Db12388
29. Khk7580; Mt-4580
30. Hy-17613
31. Ms-26062
32. Cs-0014698
33. Ns00073438
34. D11063
35. G15959
36. Q27077250
37. (4-((3s)-3-(((1r)-1-(1-naphthyl)ethyl)amino)-1-pyrrolidinyl)phenyl)acetic Acid
Molecular Weight | 374.5 g/mol |
---|---|
Molecular Formula | C24H26N2O2 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 52.6 |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 517 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
H - Systemic hormonal preparations, excl. sex hormones and insulins
H05 - Calcium homeostasis
H05B - Anti-parathyroid agents
H05BX - Other anti-parathyroid agents
H05BX06 - Evocalcet
Registration Number : 229MF10027
Registrant's Address : Osaka Prefecture, Osaka City, Chuo Ward, Doshomachi 3-2-10
Initial Date of Registration : 2017-02-08
Latest Date of Registration : --
Regulatory Info :
Registration Country : Japan
Brand Name : Orkedia
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Regulatory Info :
Registration Country : Japan
Brand Name : Orkedia
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name : Orkedia
Approval Date :
Application Number :
Registration Country : Japan
Global Sales Information
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2020 Revenue in Millions : 86
2019 Revenue in Millions : 65
Growth (%) : 32
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2021 Revenue in Millions : 84
2020 Revenue in Millions : 86
Growth (%) : 9
Main Therapeutic Indication : Endocrinology
Currency : USD
2022 Revenue in Millions : 78
2021 Revenue in Millions : 84
Growth (%) : -7
Main Therapeutic Indication : Endocrinology
Currency : USD
2023 Revenue in Millions : 71
2022 Revenue in Millions : 78
Growth (%) : 3
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2019 Revenue in Millions : 64
2018 Revenue in Millions : 22
Growth (%) : 188
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?